Immunogenic cell death and DAMPs in cancer therapy

Krysko, Dmitri V., Garg, Abhishek D., Kaczmarek, Agnieszka, Krysko, Olga, Agostinis, Patrizia, Vandenabeele, Peter·2012·Nature Reviews Cancer

Cites (211)

Items 201–211 of 211

  1. MODULATION OF P-GLYCOPROTEIN EXPRESSION IN HYPERTHYROID RAT TISSUES
    Naoki Nishio, Toshiya Katsura, Kayoko Ashida · 2005 · Drug Metabolism and Disposition
  2. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
    Huihan Wang, Xiaobin Wang, Yingchun Li · 2012 · PubMed
  3. Immunological studies of mitoxantrone in primary progressive MS
    Clara M. Pelfrey, Anne C Cotleur, Natacha Zamor, Jar-Chi Lee, Robert James Fox · 2006 · Journal of Neuroimmunology
  4. Indomethacin modulation of Adriamycin-induced effects on multiple cytolytic effector functions
    Darbie Maccubbin, Stefan A. Cohen, M. Jane Ehrke · 1990 · Cancer Immunology Immunotherapy
  5. Role of Attraction and Danger Signals in the Uptake of Apoptotic and Necrotic Cells and its Immunological Outcome
    Christoph Peter, Sebastian Wesselborg, Kirsten Lauber · 2009 · Springer eBooks
  6. Molecular basis of the low activity of antitumor anthracenediones, mitoxantrone and ametantrone, in oxygen radical generation catalyzed by NADH dehydrogenase. Enzymatic and molecular modelling studies
    Jolanta Tarasiuk, Jan Mazerski, Katarzyna Tkaczyk-Gobis, Edward Borowski · 2004 · European Journal of Medicinal Chemistry
  7. BAP31 is frequently overexpressed in patients with primary colorectal cancer and correlates with better prognosis
    Ling-yi Dong, Kewei Jiang, YanBin Zhang, Hui Zhang, Hong-qing Zhuo, Zhirong Cui, Yingjiang Ye, Shan Wang · 2011 · Chinese Science Bulletin
  8. Mitoxantrone as a Single Agent in Pretreated Metastatic Breast Cancer: Effects on T Lymphocyte Subsets and Their Relation to Clinical Response
    Sandro Barni, Paolo Lissoni, Franco Paolorossi · 1991 · Tumori Journal
  9. Immediate and short-, mid- and long-term effects of in vivo ionizing radiation exposure in BALB/c mice: I. Activation of lymphocytes and subpopulations.
    Joaquín Hernández-Godoy, Dolores Planelles Silvestre, Baltasar Balsalobre · 2010 · PubMed
  10. The tumor microenvironment: characterization, redox considerations and novel approaches for ROS-targeted gene therapy.
    Lucı́a Policastro, Irene L. Ibañez, Cintia Notcovich, Hebe Durán, Osvaldo Luis Podhajcer · 2013 · CONICET Digital (CONICET)
  11. Time trends of consumption and costs of drugs in a cancer referral centre
    Antonio Marfella, Franco Perrone, Simona Serao Creazzola · 1997 · International Journal of Oncology